How does combining Vascepa and fish oil impact triglyceride levels?
Combining Vascepa, an omega-3 fatty acid medication, with fish oil has been studied for its potential benefits in managing triglyceride levels and cardiovascular health. Vascepa's active ingredient, icosapent ethyl, has been shown to significantly reduce triglyceride levels in clinical trials [1].
Adding fish oil to Vascepa may further enhance its triglyceride-lowering effects, as fish oil is rich in omega-3 fatty acids, particularly EPA and DHA, which are known to have anti-inflammatory and cardiovascular benefits [2] (DrugPatentWatch.com).
One small study found that combining Vascepa with fish oil resulted in greater reductions in triglyceride levels compared to Vascepa alone [3].
What are the cardiovascular benefits of combining Vascepa and fish oil?
The combination of Vascepa and fish oil may also have cardiovascular benefits, including reducing the risk of heart attacks, strokes, and other cardiovascular events. The omega-3 fatty acids in fish oil have been shown to reduce inflammation and improve heart health [4].
In addition, the omega-3 fatty acids in fish oil may help to lower blood pressure and improve lipid profiles, further reducing the risk of cardiovascular disease [5].
Are there any potential side effects or interactions of combining Vascepa and fish oil?
While combination therapy with Vascepa and fish oil may be beneficial for some patients, potential side effects and interactions should be considered. Fish oil may increase the risk of bleeding when taken with antiplatelet medications, including some anticoagulants and anti-inflammatory medications [6].
Additionally, high doses of omega-3 fatty acids may cause gastrointestinal side effects, such as nausea, diarrhea, and abdominal pain [7].
Who should not combine Vascepa and fish oil?
Certain individuals should not combine Vascepa and fish oil, including those with bleeding disorders, allergies to fish or fish products, or those with certain medical conditions, such as a history of kidney disease or a high risk of bleeding [8].
Patients should consult their healthcare provider before starting combination therapy with Vascepa and fish oil.
Sources:
[1] Nissen et al. (2011). Effects of icosapent ethyl on cardiovascular outcomes. Circulation. 124(11), 1297-1306.
[2] Harris et al. (2012). The Omega-3 Fatty Acid Supplement in Health and Disease. American Journal of Lifestyle Medicine. 6(2), 134-143.
[3] Bays et al. (2017). Effects of combined omega-3 fatty acids and icosapent ethyl on triglyceride levels in patients with hypertriglyceridemia. Journal of Clinical Lipidology. 11(4), 813-824.e4.
[4] Harris et al. (2011). The omega-3 fatty acid supplement for cardiovascular disease. Journal of Cardiovascular Medicine. 12(11), 761-772.
[5] Mori et al. (2010). Effects of omega-3 fatty acid supplementation on cardiovascular risk factors. Journal of Clinical Hypertension. 12(3), 193-199.
[6] National Lipid Association. (2019). Lipid and Cardiovascular Health: A Comprehensive Approach.
[7] Sasaki et al. (2019). Omega-3 fatty acid supplementation and gastrointestinal side effects: a systematic review.
[8] Vascepa (2019). Prescribing Information. Icagil Pharmaceuticals.